If you have a history of medullary thyroid carcinoma , pancreatitis, or multiple endocrine neoplasia syndrome type 2, you will not qualify
This image has been modified
In a study of 2,539 patients assigned to take either tirzepatide or placebo for 72 weeks, the average weight loss achieved for patients taking tirzepatide 5 mg was 15%
PROMIS-Fatigue T -scores were also correlated with sulfated metabolites of androgen including androstenediol (3beta,17beta) monosulfate ( r = 0.26, p = 0.0008), 5alpha-androstan-3beta,17beta-diol disulfate ( r = 0.21, p = 0.0083), 5alpha-androstan-3beta,17beta-diol monosulfate ( r = 0.20, p = 0.012), 5alpha-androstan-3alpha,17alpha-diol monosulfate ( r = 0.22, p = 0.0062), and 5alpha-androstan-3beta,17alpha-diol disulfate ( r = 0.17, p = 0.028) (Figure 5)